HCID 59674138, compound → HCID 86601120, compound
Reaction equation
[Cl:1][C:2]1[N:7]=[C:6]([N:8]([CH3:26])[C:9]2[CH:25]=[CH:24][C:12]3[N:13]([CH3:23])[C:14]([NH:16][CH:17]4[CH2:22][CH2:21][CH2:20][CH2:19][CH2:18]4)=[N:15][C:11]=3[CH:10]=2)[CH:5]=[CH:4][N:3]=1.[CH3:27][S:28]([CH2:31][CH2:32][C:33]1[CH:34]=[C:35]([NH2:39])[CH:36]=[CH:37][CH:38]=1)(=[O:30])=[O:29]>>[ClH:1].[CH:17]1([NH:16][C:14]2[N:13]([CH3:23])[C:12]3[CH:24]=[CH:25][C:9]([N:8]([C:6]4[CH:5]=[CH:4][N:3]=[C:2]([NH:39][C:35]5[CH:36]=[CH:37][CH:38]=[C:33]([CH2:32][CH2:31][S:28]([CH3:27])(=[O:30])=[O:29])[CH:34]=5)[N:7]=4)[CH3:26])=[CH:10][C:11]=3[N:15]=2)[CH2:22][CH2:21][CH2:20][CH2:19][CH2:18]1Participants
3
Procedure
The title compound was prepared following the procedure of example 1 with N5-(2-Chloro-pyrimidin-4-yl)-N2-cyclohexyl-1,N5-dimethyl-1H-benzoimidazole-2,5-diamine (74 mg, 0.20 mmol) and 3-(2-methanesulfonyl-ethyl)-phenylamine (47 mg, 0.20 mmol) as a white solid (59 mg, 52%). 1H NMR (300 MHz, D6-DMSO) δ 9.07 (s, 1H), 7.76-7.78 (m, 2H), 7.60 (d, J=8.4 Hz, 1H), 7.13-7.20 (m, 2H), 7.09 (d, J=1.8 Hz, 1H), 6.79-6.82 (m, 2H), 6.47 (d, J=7.8 Hz, 1H), 5.61 (d, J=6.0 Hz, 1H), 3.70 (m, 1H), 3.51 (s, 3H), 3.44 (s, 3H), 3.35-3.40 (m, 2H), 2.97 (s, 3H), 2.91-2.95 (m, 2H), 2.01 (m, 2H), 1.74 (M, 2H), 1.63 (m, 1H), 1.16-1.31 (m, 5H) ppm. MS (ESI) m/z=534 [M+H]+.
Sources & evidence
- ORD record
- ord-0117e0f3e4394bd786dde1e9a2fc722c
- Source dataset
- uspto-grants-2008_03
- Patent number
- US07338959B2
Reaction notes
Loading…